This federal contract award, valued at $4,377.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orilissa 150 mg tablets and has a completion date of December 10, 2024.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract award does not have a set-aside designation, indicating open competition. As a major supplier of medical products to federal government agencies, Amerisourcebergen plays a critical role in supplying essential pharmaceuticals and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/10/25, 9:44 AM